Cargando…
Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients
Autores principales: | Walker, Gregory J., Davis, Rebecca, Naing, Zin, McEntee, Brad, Lu, Yonghui, Denadija, Tatijana, Rawlinson, William D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672893/ https://www.ncbi.nlm.nih.gov/pubmed/34908472 http://dx.doi.org/10.1128/Spectrum.01245-21 |
Ejemplares similares
-
Validation of dried blood spot sample modifications to two
commercially available COVID-19 IgG antibody immunoassays
por: Zava, Theodore T, et al.
Publicado: (2020) -
Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies
por: Kaduskar, Ojas, et al.
Publicado: (2021) -
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
por: Walker, Gregory J., et al.
Publicado: (2021) -
Validation of a commercially available SARS-CoV-2 serological immunoassay
por: Meyer, B., et al.
Publicado: (2020) -
Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots
por: Turgeon, Coleman T., et al.
Publicado: (2021)